Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $106.3 million.

  • Xtant Medical Holdings' Liabilities and Shareholders Equity rose 752.31% to $106.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $399.5 million, marking a year-over-year increase of 484.69%. This contributed to the annual value of $93.8 million for FY2024, which is 132.27% up from last year.
  • Xtant Medical Holdings' Liabilities and Shareholders Equity amounted to $106.3 million in Q3 2025, which was up 752.31% from $103.5 million recorded in Q2 2025.
  • Xtant Medical Holdings' Liabilities and Shareholders Equity's 5-year high stood at $106.3 million during Q3 2025, with a 5-year trough of $52.7 million in Q2 2022.
  • Over the past 5 years, Xtant Medical Holdings' median Liabilities and Shareholders Equity value was $65.2 million (recorded in 2023), while the average stood at $76.4 million.
  • Per our database at Business Quant, Xtant Medical Holdings' Liabilities and Shareholders Equity tumbled by 1166.8% in 2022 and then soared by 6414.74% in 2023.
  • Xtant Medical Holdings' Liabilities and Shareholders Equity (Quarter) stood at $54.7 million in 2021, then grew by 10.12% to $60.2 million in 2022, then skyrocketed by 53.77% to $92.6 million in 2023, then increased by 1.32% to $93.8 million in 2024, then grew by 13.3% to $106.3 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $106.3 million for Q3 2025, versus $103.5 million for Q2 2025 and $95.8 million for Q1 2025.